Welcome to Markets Desk, here's what's moving the needle this hour.
Social Security confirmed a policy change announced June second that has beneficiaries on edge. Details remain limited, but the agency is pressing forward despite public pushback, and for millions of Americans depending on those monthly payments, any structural shift carries real financial weight.
Shifting to retail operations, Target has quietly solved a friction problem costing its drive-up teams significant time each shift. Store renovations had left workers needing roughly thirty seconds to re-enter the building after each curbside delivery, and across hundreds of daily orders, that compounded into meaningful lost labor hours. A new tech fix eliminates the delay entirely, and at scale, that kind of operational efficiency flows directly to the bottom line.
On the regulatory front, OncoSil Medical has submitted a Humanitarian Device Exemption application to the FDA for its OncoSil device, targeting distal cholangiocarcinoma, a rare and difficult-to-treat bile duct cancer. The HDE pathway is designed specifically for conditions affecting smaller patient populations, and a successful review would mark a significant commercial milestone for the Australian medical device maker.
That's the tape. Markets Desk, signing off the floor.
